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Summary
Patients suffering from burn-related injuries admitted to the hospital 
concurrently using nicotine and/or smoke are believed to be at an increased 
risk of poor outcomes and the development of complications following burn 
reconstruction, however data varies within the literature and remains 
controversial. This systematic review and meta-analysis compared outcomes 
and complications from studies during the years 1986 to 2018 between 8568 
burn patients admitted to the hospital who use nicotine and/or smoke to 
299543 burn patients admitted who do not use nicotine and/or smoke. The 
PubMed, EMBASE, Cochrane Library, and Web of Science databases were 
systematically and independently searched. Clinical characteristics, 
nicotine/smoking use, outcomes and complications were recorded. PRISMA 
and Cochrane guidelines where used throughout the review. Five of the 9 
studies included in our study, were eligible for meta-analysis, with results 
from 7 of the possible 21 outcomes and complications queried. In conclusion, 
this systematic review and meta-analysis found that compared to patients 
suffering from burn-related injuries who do not use nicotine and/or smoke, 
patients using nicotine/smoking were found to have a higher rate of intubation 
and more wound/local skin infections. 
ABSTRACT
INTRODUCTION
Preferred Reporting Items for Systematic Reviews and Meta-Analysis 
(PRISMA) guidelines11 were followed throughout the literature search process 
to structure the framework for the review. 
Search
A medical library informationist (SMS) conducted the initial literature search 
using four databases (MEDLINE via PubMed, Embase, Cochrane, and Web of 
Science) from inception to December 20, 2018. Reference lists of relevant 
articles were hand searched to identify additional relevant studies. All 
references were imported into Covidence (Veritas Health Innovation Ltd, 




Three studies evaluated %TBSA. 17, 24, 27 In two studies, means ranged from 
4% to 12% TBSA in 130 patients consuming nicotine or smoking compared to 
4% to 24.4% TBSA in 478 patients not consuming nicotine or smoking. These 
results were not significant (SMD: -0.38, 95% CI: -0.81, 0.04, I2 = 41%, p = 
0.08).17, 27
Hospital LOS
Four studies evaluated hospital LOS. 17, 19, 24, 27 In two studies, hospital LOS 
means ranged from 11.4 to 37 days in 130 patients consuming nicotine or 
smoking compared to 16.2 to 37 days in 478 patients not consuming nicotine 
or smoking. These results were not significant (SMD: -0.02, 95% CI: -0.22, 
0.18, I2 = 0%, p = 0.84).17, 27
Ventilator days
Two studies evaluated the number of days patients were on a ventilator. 17, 19
One study found a mean number of days a patient was on a ventilator of 5.7 
days in 14 patients consuming nicotine or smoking compared to 6 days in 14 
patients not consuming nicotine or smoking. These results were not significant 
(SMD: -0.02, 95% CI: -0.76, 0.72, I2 = Not applicable, p = 0.95). 17
Intubation
Three studies evaluated rates of intubation. 17, 19, 27 One study was available 
that assessed a mean number of patients intubated. A mean of 23 patients 
consuming nicotine or smoking was compared to a mean of 21 patients not 
consuming nicotine or smoking. (RR: 4.38, 95% CI: 2.51, 7.63, I2 = Not 
applicable, p < 0.00001). 27
ICU LOS 
Two studies evaluated ICU LOS. 19, 27 One study found a mean ICU LOS of 
28.3 days in 116 patients consuming nicotine or smoking compared to 28.4 
days in 464 patients not consuming nicotine or smoking. These results were 
not significant (SMD: -0.00, 95% CI: -0.21, 0.20, I2 = Not applicable, p = 
0.98). 27
Mortality
Five studies evaluated mortality. 7, 17, 19, 21, 27 In four studies, mortality occurred 
in 94/388 (24%) patients consuming nicotine or smoking compared to 
177/1140 (16%) patients not consuming nicotine or smoking. These results 
were not significant (RR: 1.53, 95% CI: 0.36, 6.53, I2 = 96%, p = 0.56). 7, 17, 21, 
27 After removing the study Knowlin et al, heterogeneity dropped from I2 = 
96% to I2 = 91%, with a p = 0.56 to p = 0.04. 27 No single study could be 
identified for the high heterogeneity.7, 17, 21, 27
Wound/local skin infections
One study found 344/8180 (4%) cellulitis infections in patients consuming 
nicotine or smoking compared to 3399/129091 (2.6%) cellulitis infections in 
patients not consuming nicotine or smoking (RR: 1.44, 95% CI: 1.09, 1.90, I2




Compared to patients suffering from burn-related injuries who do not use 
nicotine and/or smoke, patients using nicotine/smoking were found to have a 
higher rate of intubation and more wound/local skin infections. 
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This new systematic review and meta-analysis compared outcomes and 
complications between nicotine/smoking use in burn patients admitted to the 
hospital to burn patients admitted without these characteristics. This review is 
an attempt to compile information to create a uniform set of data for clinical 
interpretation in diverse populations. Based on peer-reviewed literature, it was 
hypothesized that nicotine/smoking would increase the risks of poor outcomes 
and complications in patients admitted to the hospital following a burn related 
injury, compared to burn patients admitted without any of these 
characteristics. 
Data Extraction
Two reviewers (KMK and PS) systematically and independently performed the 
title screening, followed by abstract screening, and full-article review to ensure 
quality and accuracy throughout the process. Any disagreements regarding 
studies to be included or excluded were resolved by discussion. If disagreements 
were still present after discussion, a third reviewer (CSH) resolved remaining 
conflict. The following data were extracted qualitatively and quantitatively for 
outcome and complication variables of interest: authors, year of publication, 
type of study, sample size, male and female distributions, nicotine/smoking used 
on admission to the hospital, burn related operations, graft loss/failure, percent 
total body surface area burned (%TBSA), depth of burn (superficial, superficial 
partial thickness, deep partial thickness, full thickness), skin grafting, 
amputations, length of hospital stay (LOS), time period of wound closure, 
inhalation injury, number of days on a ventilator, rate of intubation, intensive 
care unit (ICU) LOS, mortality, overall infections, wound/local skin infections, 
sepsis, decubitus ulcer (hospital acquired pressure injury), deep vein thrombosis 
(DVT)/pulmonary embolism (PE), renal failure, respiratory complications, and 
ventilator-associated events. If there were multiple reports from the same study, 
one data collection form was completed for the study from all of the reports to 
avoid duplicating results. 
MATERIAL AND METHODS
